Want to join the conversation?
Related to the acquisition of Par Pharmaceutical on Sept. 25, 2015, $ENDP implemented cost-rationalization and integration initiatives to capture operating synergies and generate cost savings across the company. The cost reduction initiatives included a reduction in headcount of approx. 6% of the former Par and Qualitest workforces.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.